1. Increased ID4 expression, accompanied by mutant p53 accumulation and loss of BRCA1/2 proteins in triple-negative breast cancer, adversely affects survival
    Aye A. Thike et al, 2016, Histopathology CrossRef
  2. Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients
    Xiaorong Zhong et al, 2016, PLOS ONE CrossRef
  3. Triple negative breast cancer in North of Morocco: clinicopathologic and prognostic features
    Touria Derkaoui et al, 2016, BMC Women's Health CrossRef
  4. Prevalence of BRCA1 mutations and responses to neoadjuvant chemotherapy among BRCA1 carriers and non-carriers with triple-negative breast cancer
    C. Wang et al, 2015, Annals of Oncology CrossRef
  5. Le cancer du sein triple-négatif. Le triple-négatif est fréquent chez les patientes mutées : comment ne pas le rater ? Comment le caractériser ? De manière plus générale, l’imagerie peut-elle orienter vers le diagnostic histologique ?
    Martine Boisserie-Lacroix et al, 2014, Imagerie de la Femme CrossRef
  6. High expression of miR-214 is associated with a worse disease-specific survival of the triple-negative breast cancer patients
    Dagnija Kalniete et al, 2015, Hereditary Cancer in Clinical Practice CrossRef
  7. Accumulation of cytoplasmic Cdk1 is associated with cancer growth and survival rate in epithelial ovarian cancer
    Wookyeom Yang et al, 2016, Oncotarget CrossRef
  8. Platinum-based neoadjuvant chemotherapy in BRCA1-positive breast cancer: a retrospective cohort analysis and literature review
    Nikolai Havn Sæther et al, 2018, Hereditary Cancer in Clinical Practice CrossRef
  9. Evaluation of Complete Pathological Regression after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients with BRCA1 Founder Mutation Aided Bayesian A/B Testing Approach
    Piotr Kedzierawski et al, 2021, Diagnostics CrossRef
  10. Effects of BRCA Germline Mutations on Triple-Negative Breast Cancer Prognosis
    Katarzyna Pogoda et al, 2020, Journal of Oncology CrossRef
  11. Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea
    null null et al, 2019, Breast Cancer Research and Treatment CrossRef
  12. Effect of BRCA germline mutations on breast cancer prognosis
    Zora Baretta et al, 2016, Medicine CrossRef
  13. Integrating mutation and gene expression cross-sectional data to infer cancer progression
    Julia L. Fleck et al, 2016, BMC Systems Biology CrossRef
  14. Prognostic Impact of BRCA1 and BRCA2 Mutations on Long-Term Survival Outcomes in Egyptian Female Breast Cancer Patients
    Sherihan AbdelHamid et al, 2021, Biology CrossRef
  15. Her2-neu score as a prognostic factor for outcome in patients with triple-negative breast cancer
    Gilda Schmidt et al, 2016, Journal of Cancer Research and Clinical Oncology CrossRef
  16. Impact of BRCA Mutation Status on Survival of Women With Triple-negative Breast Cancer
    Siddhartha Yadav et al, 2018, Clinical Breast Cancer CrossRef
  17. Mutations in tumor suppressor genes and their relationship with phenotypic features of breast cancer in young age women
    Lyudmila A. Gordeeva et al, 2018, Ecological genetics CrossRef